Results 81 to 90 of about 291 (113)
Some of the next articles are maybe not open access.
A pharmacological profile of somapacitan for the treatment of growth hormone deficiency
Expert Review of Clinical PharmacologyLong-acting growth hormone (LAGH) preparations have been developed to reduce the burden of daily injections and improve compliance in children and adults with growth hormone deficiency (GHD). Somapacitan is the only LAGH approved for both pediatric and adult GHD that has been in the market for nearly 2 years for these indications.
Heba Al-Rayess, Bradley S Miller
exaly +3 more sources